Long-Term Efficacy of Lacosamide as Adjunctive Therapy in Patients with Uncontrolled POS: Results from a Phase III Open-Label Extension Trial

被引：0
|
作者：
Chung, Steve
Faught, Raymond Edward
Husain, Aatif
Isojarvi, Jouko
Doty, Pamela
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A376 / A376
页数：1
相关论文
共 50 条
  • [1] LONG-TERM SAFETY AND EFFICACY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN PATIENTS WITH UNCONTROLLED POS: RESULTS FROM A PHASE III OPEN-LABEL EXTENSION TRIAL
    Husain, A.
    Faught, E.
    Chung, S.
    Isojarvi, J.
    McShea, C.
    Doty, P.
    [J]. EPILEPSIA, 2011, 52 : 155 - 155
  • [2] Long-Term Safety of Lacosamide as Adjunctive Therapy in Patients with Uncontrolled Partial-Onset Seizures: Results from a Phase III Open-Label Extension Trial
    Husain, Aatif
    Faught, Raymond Edward
    Chung, Steve
    Isojarvi, Jouko
    McShea, Cindy
    Doty, Pamela
    [J]. NEUROLOGY, 2011, 76 (09) : A291 - A291
  • [3] Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: Results from a phase III open-label extension trial
    Husain, Aatif
    Chung, Steve
    Faught, Edward
    Isojarvi, Jouko
    McShea, Cindy
    Doty, Pamela
    [J]. EPILEPSIA, 2012, 53 (03) : 521 - 528
  • [4] LONG-TERM ADJUNCTIVE LACOSAMIDE IN PATIENTS WITH UNCONTROLLED PARTIAL-ONSET SEIZURES: RESULTS FROM THE SP774 PHASE III OPEN-LABEL EXTENSION TRIAL
    Rosenow, F.
    Kelemen, A.
    Ben-Menachem, E.
    McShea, C.
    Isojarvi, J.
    Doty, P.
    [J]. EPILEPSIA, 2011, 52 : 156 - 156
  • [5] Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
    Klein, Pavel
    Aboumatar, Sami
    Brandt, Christian
    Dong, Fang
    Krauss, Gregory L.
    Mizne, Sarah
    Sanchez-Alvarez, Juan Carlos
    Steinhoff, Bernhard J.
    Villanueva, Vicente
    [J]. NEUROLOGY, 2022, 99 (10) : E989 - E998
  • [6] An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia
    Murakami, Masato
    Osada, Kenichi
    Ichibayashi, Hisao
    Mizuno, Hiromichi
    Ochiai, Toshimitsu
    Ishida, Mitsuhiro
    Alev, Levent
    Nishioka, Kusuki
    [J]. MODERN RHEUMATOLOGY, 2017, 27 (04) : 688 - 695
  • [7] Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years
    Rosenfeld, William
    Fountain, Nathan B.
    Kaubrys, Gintaras
    Ben-Menachemd, Elinor
    McShea, Cindy
    Isojarvi, Jouko
    Doty, Pamela
    [J]. EPILEPSY & BEHAVIOR, 2014, 41 : 164 - 170
  • [8] An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia
    Ohta, Hiroyoshi
    Oka, Hiroshi
    Usui, Chie
    Ohkura, Masayuki
    Suzuki, Makoto
    Nishioka, Kusuki
    [J]. MODERN RHEUMATOLOGY, 2013, 23 (06) : 1108 - 1115
  • [9] Long-term Efficacy and Safety of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures: Open-label Extension of a Randomized Clinical Study
    Klein, Pavel
    Krauss, Gregory
    Aboumatar, Sami
    Kamin, Marc
    [J]. NEUROLOGY, 2020, 94 (15)
  • [10] Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial
    Etsuro Mori
    Manabu Ikeda
    Reiko Nagai
    Kazutaka Matsuo
    Masaki Nakagawa
    Kenji Kosaka
    [J]. Alzheimer's Research & Therapy, 7
12345